INOVIO PHARMACEUTICALS, INC. Earnings Per Share (Basic)
INOVIO PHARMACEUTICALS, INC. (INO) reported Earnings Per Share (Basic) of -$0.07 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-12
- INOVIO PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.07.
- INOVIO PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.28.
- INOVIO PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.87.
- INOVIO PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.61.
- INOVIO PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2025 was -$1.81.
- INOVIO PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2024 was -$3.95.
- INOVIO PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2023 was -$6.09.
- INOVIO PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2022 was -$14.07.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.07 10-Q · filed 2026-08-12 | -$0.34 10-Q · filed 2026-08-12 | ||||||
| 2026-03-31 | -$0.28 10-Q · filed 2026-05-13 | |||||||
| 2025-12-31 | -$1.81 10-K · filed 2026-03-12 | |||||||
| 2025-09-30 | -$0.87 10-Q · filed 2025-11-10 | -$2.12 10-Q · filed 2025-11-10 | ||||||
| 2025-06-30 | -$0.61 10-Q · filed 2026-08-12 | -$1.12 10-Q · filed 2026-08-12 | ||||||
| 2025-03-31 | -$0.51 10-Q · filed 2026-05-13 | |||||||
| 2024-12-31 | -$3.95 10-K · filed 2026-03-12 | |||||||
| 2024-09-30 | -$0.89 10-Q · filed 2025-11-10 | -$3.35 10-Q · filed 2025-11-10 | ||||||
| 2024-06-30 | -$1.19 10-Q · filed 2025-08-12 | -$2.48 10-Q · filed 2025-08-12 | ||||||
| 2024-03-31 | -$1.31 10-Q · filed 2025-05-13 | |||||||
| 2023-12-31 | -$6.09 10-K · filed 2025-03-18 | |||||||
| 2023-09-30 | -$1.52 10-Q · filed 2024-11-14 | -$0.13 10-Q · filed 2023-11-09 | -$5.01 10-Q · filed 2024-11-14 | -$0.42 10-Q · filed 2023-11-09 | ||||
| 2023-06-30 | -$1.61 10-Q · filed 2024-08-08 | -$0.13 10-Q · filed 2023-08-09 | -$3.50 10-Q · filed 2024-08-08 | -$0.29 10-Q · filed 2023-08-09 | ||||
| 2023-03-31 | -$1.89 10-Q · filed 2024-05-13 | -$0.16 10-Q · filed 2023-05-10 | ||||||
| 2022-12-31 | -$14.07 10-K · filed 2024-03-06 | -$1.17 10-K · filed 2023-03-01 | ||||||
| 2022-09-30 | -$0.15 10-Q · filed 2023-11-09 | -$0.96 10-Q · filed 2023-11-09 | ||||||
| 2022-06-30 | -$0.46 10-Q · filed 2023-08-09 | -$0.83 10-Q · filed 2023-08-09 | ||||||
| 2022-03-31 | -$0.36 10-Q · filed 2023-05-10 | |||||||
| 2021-12-31 | -$17.45 10-K · filed 2024-03-06 | -$1.45 10-K · filed 2022-03-01 | ||||||
| 2021-09-30 | -$0.29 10-Q · filed 2022-11-08 | -$0.95 10-Q · filed 2022-11-08 | ||||||
| 2021-06-30 | -$0.39 10-Q · filed 2022-08-09 | -$0.66 10-Q · filed 2022-08-09 | ||||||
| 2021-03-31 | -$0.27 10-Q · filed 2022-05-10 | |||||||
| 2020-12-31 | -$0.14 10-K · filed 2021-03-01 | -$1.07 10-K · filed 2023-03-01 | ||||||
| 2020-09-30 | $0.12 10-Q · filed 2021-11-09 | -$0.96 10-Q · filed 2021-11-09 | ||||||
| 2020-06-30 | -$0.83 10-Q · filed 2021-08-09 | -$1.15 10-Q · filed 2021-08-09 | ||||||
| 2020-03-31 | -$0.26 10-K · filed 2021-03-01 | |||||||
| 2019-12-31 | -$0.38 10-K · filed 2021-03-01 | -$1.21 10-K · filed 2022-03-01 | ||||||
| 2019-09-30 | -$0.23 10-K · filed 2021-03-01 | -$0.83 10-Q · filed 2020-11-09 | ||||||
| 2019-06-30 | -$0.30 10-K · filed 2021-03-01 | -$0.60 10-Q · filed 2019-08-08 | ||||||
| 2019-03-31 | -$0.30 10-K · filed 2021-03-01 | |||||||
| 2018-12-31 | -$0.34 10-K · filed 2020-03-12 | -$0.62 derived: net income ÷ weighted average shares · filed 2020-03-12 | -$0.70 derived: net income ÷ weighted average shares · filed 2020-03-12 | -$1.05 10-K · filed 2020-03-12 | ||||
| 2018-09-30 | -$0.27 10-K · filed 2020-03-12 | -$0.35 derived: net income ÷ weighted average shares · filed 2019-11-12 | -$0.70 10-Q · filed 2019-11-12 | -$0.95 derived: net income ÷ weighted average shares · filed 2020-03-12 | ||||
| 2018-06-30 | -$0.07 10-K · filed 2020-03-12 | -$0.43 10-Q · filed 2019-08-08 | -$0.68 derived: net income ÷ weighted average shares · filed 2020-03-12 | -$1.07 derived: net income ÷ weighted average shares · filed 2020-03-12 | ||||
| 2018-03-31 | -$0.36 10-K · filed 2020-03-12 | -$0.60 derived: net income ÷ weighted average shares · filed 2020-03-12 | -$1.00 derived: net income ÷ weighted average shares · filed 2020-03-12 | -$1.15 derived: net income ÷ weighted average shares · filed 2020-03-12 | ||||
| 2017-12-31 | -$0.24 10-K · filed 2019-03-12 | -$0.64 derived: net income ÷ weighted average shares · filed 2020-03-12 | -$0.78 derived: net income ÷ weighted average shares · filed 2020-03-12 | -$1.08 10-K · filed 2020-03-12 | ||||
| 2017-09-30 | -$0.39 10-K · filed 2019-03-12 | -$0.54 derived: net income ÷ weighted average shares · filed 2018-11-08 | -$0.85 10-Q · filed 2018-11-08 | -$1.20 derived: net income ÷ weighted average shares · filed 2019-03-12 | ||||
| 2017-06-30 | -$0.13 10-K · filed 2019-03-12 | -$0.44 10-Q · filed 2018-08-07 | -$0.79 derived: net income ÷ weighted average shares · filed 2019-03-12 | -$1.07 derived: net income ÷ weighted average shares · filed 2019-03-12 | ||||
| 2017-03-31 | -$0.31 10-K · filed 2019-03-12 | -$0.67 derived: net income ÷ weighted average shares · filed 2019-03-12 | -$0.95 derived: net income ÷ weighted average shares · filed 2019-03-12 | -$1.21 derived: net income ÷ weighted average shares · filed 2019-03-12 | ||||
| 2016-12-31 | -$0.35 10-K · filed 2018-03-14 | -$0.64 derived: net income ÷ weighted average shares · filed 2019-03-12 | -$0.89 derived: net income ÷ weighted average shares · filed 2019-03-12 | -$1.01 10-K · filed 2019-03-12 | ||||
| 2016-09-30 | -$0.28 10-K · filed 2018-03-14 | -$0.54 derived: net income ÷ weighted average shares · filed 2017-11-08 | -$0.65 10-Q · filed 2017-11-08 | -$0.90 derived: net income ÷ weighted average shares · filed 2018-03-14 | ||||
| 2016-06-30 | -$0.26 10-K · filed 2018-03-14 | -$0.37 10-Q · filed 2016-08-08 | -$0.61 derived: net income ÷ weighted average shares · filed 2018-03-14 | -$0.55 derived: net income ÷ weighted average shares · filed 2018-03-14 | ||||
| 2016-03-31 | -$0.11 10-K · filed 2018-03-14 | -$0.36 derived: net income ÷ weighted average shares · filed 2018-03-14 | -$0.29 derived: net income ÷ weighted average shares · filed 2018-03-14 | -$0.38 derived: net income ÷ weighted average shares · filed 2018-03-14 | ||||
| 2015-12-31 | -$0.25 10-K · filed 2017-03-15 | -$0.18 derived: net income ÷ weighted average shares · filed 2018-03-14 | -$0.27 derived: net income ÷ weighted average shares · filed 2018-03-14 | -$0.43 10-K · filed 2018-03-14 | ||||
| 2015-09-30 | $0.08 10-K · filed 2017-03-15 | -$0.02 derived: net income ÷ weighted average shares · filed 2016-11-09 | -$0.17 10-Q · filed 2016-11-09 | -$0.30 derived: net income ÷ weighted average shares · filed 2017-03-15 | ||||
| 2015-06-30 | -$0.09 10-K · filed 2017-03-15 | -$0.26 10-Q · filed 2016-08-08 | -$0.39 derived: net income ÷ weighted average shares · filed 2017-03-15 | -$0.52 derived: net income ÷ weighted average shares · filed 2017-03-15 | ||||
| 2015-03-31 | -$0.17 10-K · filed 2017-03-15 | -$0.30 derived: net income ÷ weighted average shares · filed 2017-03-15 | -$0.43 derived: net income ÷ weighted average shares · filed 2017-03-15 | -$0.62 derived: net income ÷ weighted average shares · filed 2017-03-15 | ||||
| 2014-12-31 | -$0.12 10-K · filed 2016-03-14 | -$0.25 derived: net income ÷ weighted average shares · filed 2017-03-15 | -$0.44 derived: net income ÷ weighted average shares · filed 2017-03-15 | -$0.61 10-K · filed 2017-03-15 | ||||
| 2014-09-30 | -$0.12 10-K · filed 2016-03-14 | -$0.32 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$0.49 10-Q · filed 2015-11-09 | -$0.80 derived: net income ÷ weighted average shares · filed 2016-03-14 | ||||
| 2014-06-30 | -$0.18 10-K · filed 2016-03-14 | -$0.37 10-Q · filed 2015-08-10 | -$0.68 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$1.28 derived: net income ÷ weighted average shares · filed 2016-03-14 | ||||
| 2014-03-31 | -$0.20 10-K · filed 2016-03-14 | -$0.49 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$1.10 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$1.36 derived: net income ÷ weighted average shares · filed 2016-03-14 | ||||
| 2013-12-31 | -$0.30 10-K · filed 2015-03-16 | -$0.93 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$1.18 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$1.43 10-K · filed 2016-03-14 | ||||
| 2013-09-30 | -$0.64 10-K · filed 2015-03-16 | -$0.90 derived: net income ÷ weighted average shares · filed 2015-03-16 | -$1.15 10-Q · filed 2014-11-10 | |||||
| 2013-06-30 | -$0.24 10-K · filed 2015-03-16 | -$0.47 10-Q · filed 2014-08-11 | ||||||
| 2013-03-31 | -$0.23 10-K · filed 2015-03-16 | |||||||
| 2012-12-31 | -$0.58 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |